Guardant Health Target Price

Analysts' average 12-month price target for Guardant Health is $180.

Get informed when a big investor buys or sells

+ Follow

Share Price

$165.11

Average Target Price

$178.33

8% upside

27 analysts in the last 4 months

High: $210 | Low: $115

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-04	Morgan Stanley	$185	12% upside
2026-08-04	Stephens	$195	18.1% upside
2026-08-04	Piper Sandler	$193	16.9% upside
2026-07-31	RBC CapitalDan Leonard	$200	21.1% upside
2026-07-31	RBC Capital	$210	27.2% upside
2026-07-31	Stifel NicolausDaniel Arias	$180	9% upside
2026-07-31	Goldman Sachs	$210	27.2% upside
2026-07-31	Mizuho SecuritiesAnthony Petrone	$200	21.1% upside
2026-07-31	BTIGMark Massaro	$195	18.1% upside
2026-07-31	Barclays	$200	21.1% upside
2026-07-16	Guggenheim	$190	15.1% upside
2026-07-14	Canaccord GenuityKyle Mikson	$205	24.2% upside
2026-07-09	Morgan Stanley	$175	6% upside
2026-07-06	Evercore ISIVijay Kumar	$200	21.1% upside
2026-07-02	BernsteinEve Burstein	$200	21.1% upside
2026-07-01	BTIG	$190	15.1% upside
2026-06-29	Guggenheim	$160	3.1% downside
2026-06-24	UBS	$150	9.2% downside
2026-06-11	RBC CapitalDan Leonard	$185	12% upside
2026-06-08	Mizuho Securities	$175	6% upside
2026-06-05	Goldman SachsEvie Koslosky	$165	0.1% downside
2026-06-02	Evercore ISI	$160	3.1% downside
2026-05-27	BTIG	$160	3.1% downside
2026-05-26	BTIGMark Massaro	$155	6.1% downside
2026-05-21	Piper Sandler	$127	23.1% downside
2026-05-12	Piper SandlerDavid Westenberg	$135	18.2% downside
2026-04-14	BarclaysLuke Sergott	$115	30.3% downside
2026-02-24	Piper Sandler	$130	21.3% downside
2026-02-23	Raymond James	$129	21.9% downside
2026-02-20	Evercore ISI	$110	33.4% downside
2026-02-20	BTIG	$145	12.2% downside
2026-02-20	Stifel Nicolaus	$130	21.3% downside
2026-02-20	Canaccord Genuity	$135	18.2% downside
2026-02-20	Barclays	$130	21.3% downside
2026-02-17	Robert W. BairdCatherine Schulte	$120	27.3% downside
2026-01-30	UBS	$175	6% upside
2026-01-26	Guggenheim	$135	18.2% downside
2026-01-09	Stifel Nicolaus	$120	27.3% downside
2026-01-09	Mizuho Securities	$135	18.2% downside
2026-01-05	GuggenheimSubbu Nambi	$115	30.3% downside
2026-01-05	Evercore ISIVijay Kumar	$105	36.4% downside
2025-12-22	Canaccord Genuity	$125	24.3% downside
2025-12-17	Mizuho Securities	$120	27.3% downside
2025-12-15	Leerink Partners	$155	6.1% downside
2025-12-15	Wells FargoBrandon Couillard	$120	27.3% downside
2025-12-15	Barclays	$120	27.3% downside
2025-12-12	BTIG	$140	15.2% downside
2025-12-01	Morgan StanleyTejas Savant	$130	21.3% downside
2025-10-30	UBSDan Leonard	$110	33.4% downside
2025-10-30	BTIGMark Massaro	$100	39.4% downside

Guardant Health (GH) FAQ

Guardant Health's target price stands at $180. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $180 for GH implies 8.0% upside versus today's price ($165.11). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Guardant Health's target price evolved across reporting periods, while the comparison chart places GH next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Guardant Health's reading of $180 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.